We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Researchers Investigate Cause of Contrast Agent Deposits in MS Patients

By MedImaging International staff writers
Posted on 20 Dec 2016
Print article
Image: A comparison of MRI exams carried out with and without gadolinium-based contrast agents (Photo courtesy of Radiology Journal).
Image: A comparison of MRI exams carried out with and without gadolinium-based contrast agents (Photo courtesy of Radiology Journal).
The results of a new study involving multiple sclerosis patients, show how performing repeated MRI scans on the patients with gadolinium-based contrast agents leads to the deposition of the agents in the brains of the scanning subjects.

The researchers from the Charité - Universitätsmedizin Berlin (Berlin, Germany) and the Max Delbrück Center for Molecular Medicine (Berlin, Germany) compared the use of linear and macrocyclic gadolinium-based MRI contrast agents, and how their use led to the deposition of the agents in multiple sclerosis patients’ brains.

The results of the study, published in the December 2016 issue of the journal Multiple Sclerosis, suggest that the use of 'macrocylcic contrast agents' reduces the risk of accumulation of the agents in the brain.

Study leader PD Dr. Michael Scheel, said, "Patients who received a different type of MRI contrast agent - one that is referred to as a macrocyclic contrast agent - showed no evidence of gadolinium brain deposition. Available data currently suggest that the risk of deposits is considerably higher with contrast agents that have a linear molecular structure. This effect appears to be absent, or much reduced, when using contrast agents with a ring-shaped, macrocyclic structure."

Related Links:
Charité - Universitätsmedizin Berlin
Max Delbrück Center for Molecular Medicine
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound Doppler System
Doppler BT-200
MRI System
uMR 588
New
Brachytherapy Planning System
Oncentra Brachy

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.